4.5 Article

An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Rebecca P. Payne et al.

Summary: The study demonstrates that the first dose of the BNT162b2 mRNA vaccine can induce protection against the B.1.1.7 variant within weeks, and extending the interval between doses can result in higher levels of neutralizing antibody response. Prior infection with the virus can accelerate the immune response.
Article Immunology

Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial

Cassandra Aldrich et al.

Summary: Immune responses to rabies virus glycoprotein (RABV-G)-mRNA vaccine were dependent on the route of administration, necessitating specialized devices. The results showed that the 1 or 2 microgram doses were well tolerated and elicited rabies neutralizing antibody responses that met WHO criteria in all recipients.

VACCINE (2021)

Review Biochemistry & Molecular Biology

mRNA vaccine: a potential therapeutic strategy

Yang Wang et al.

Summary: mRNA vaccines have great potential in fighting cancer and viral diseases, with advancements in sequence optimization and delivery strategies to enhance efficacy and stability, and importance in increasing antigen reactivity.

MOLECULAR CANCER (2021)

Review Biochemistry & Molecular Biology

Clinical and immunological effects of mRNA vaccines in malignant diseases

Annkristin Heine et al.

Summary: mRNA-based therapeutics are considered as a novel and efficient class of drugs, with recent studies demonstrating their potential efficacy in treating various malignant and infectious diseases. Direct application of mRNA or electroporation into dendritic cells can induce immune responses and produce protective antibodies.

MOLECULAR CANCER (2021)

Article Medicine, Research & Experimental

A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus

Cai He et al.

Summary: The study found that the S1-Mut antigens were more effective in inhibiting ACE2 binding in the B.1.351 variant. Additionally, the bivalent vaccine exhibited ideal neutralization properties against the wild-type and B.1.351 variant, as well as other variants.

MEDCOMM (2021)

Article Medicine, Research & Experimental

Potent neutralizing RBD-specific antibody cocktail against SARS-CoV-2 and its mutant

Lina Jia et al.

Summary: This study identified high-affinity RBD-specific antibodies from mice vaccinated with a recombinant SARS-CoV-2 RBD, which demonstrated high potency in neutralizing both live and pseudotype SARS-CoV-2 viruses. The identified mAbs targeting different epitopes on the RBD can be used to make mAb cocktails against SARS-CoV-2 and its mutants, providing potential therapeutic and prophylactic interventions.

MEDCOMM (2021)

Review Immunology

The promise of mRNA vaccines: a biotech and industrial perspective

Nicholas A. C. Jackson et al.

NPJ VACCINES (2020)

Review Biotechnology & Applied Microbiology

mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases

Giulietta Maruggi et al.

MOLECULAR THERAPY (2019)

Review Infectious Diseases

Rabies: changing prophylaxis and new insights in pathophysiology

Gabriella Ugolini et al.

CURRENT OPINION IN INFECTIOUS DISEASES (2018)

Review Biotechnology & Applied Microbiology

mRNA vaccines - a new era in vaccinology

Norbert Pardi et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Review Microbiology

The spread and evolution of rabies virus: conquering new frontiers

Christine R. Fisher et al.

NATURE REVIEWS MICROBIOLOGY (2018)

Article Infectious Diseases

Estimating the Global Burden of Endemic Canine Rabies

Katie Hampson et al.

PLOS NEGLECTED TROPICAL DISEASES (2015)

Article Virology

Everything You Always Wanted to Know About Rabies Virus (But Were Afraid to Ask)

Benjamin M. Davis et al.

ANNUAL REVIEW OF VIROLOGY, VOL 2 (2015)

Article Biotechnology & Applied Microbiology

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

Benjamin Petsch et al.

NATURE BIOTECHNOLOGY (2012)

Review Virology

Molecular and Cellular Aspects of Rhabdovirus Entry

Aurelie A. V. Albertini et al.

VIRUSES-BASEL (2012)

Article Virology

Characterization of human rabies virus vaccine strain in China

Jialiang Du et al.

VIRUS RESEARCH (2008)

Article Biochemistry & Molecular Biology

High guanine and cytosine content increases mRNA levels in mammalian cells

Grzegorz Kudla et al.

PLOS BIOLOGY (2006)

Article Virology

Oral vaccination of dogs with recombinant rabies virus vaccines

CE Rupprecht et al.

VIRUS RESEARCH (2005)

Article Medicine, General & Internal

Brief report: Human infection due to recombinant vaccinia-rabies glycoprotein virus

CE Rupprecht et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Article Biotechnology & Applied Microbiology

Spread and pathogenic characteristics of a G-deficient rabies virus recombinant:: an in vitro and in vivo study

R Etessami et al.

JOURNAL OF GENERAL VIROLOGY (2000)